Autobio Diagnostics Co., Ltd. (SHA:603658)
China flag China · Delayed Price · Currency is CNY
38.30
+0.08 (0.21%)
Nov 13, 2026, 3:00 PM CST

Autobio Diagnostics Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
4,2544,1414,3894,3684,3663,686
Other Revenue
85.1785.1781.9876.0575.7679.82
4,3394,2264,4714,4444,4423,766
Revenue Growth
2.86%-5.47%0.62%0.05%17.94%26.45%
Cost of Revenue
1,4211,5021,5821,6121,8441,545
Gross Profit
2,9182,7242,8892,8322,5972,221
Selling, General & Admin
1,1201,061953.05920.21857.11757.02
Research & Development
627.01555.12731.93656.13568.48480.96
Other Operating Expenses
57.8733.5-3.2528.0528.2413.73
Operating Expenses
1,8211,6621,7371,6261,4711,267
Operating Income
1,0961,0621,1521,2061,126954.28
Interest Expense
-9.35-13.96-22.28-24.54-21.23-12.68
Interest & Investment Income
72.91111.59112.84144.76135.09116.43
Currency Exchange Gain (Loss)
-1.6-1.60.631.197.47-9.65
Other Non Operating Income (Expenses)
-39.813.36-2.08-2.9-5.180.77
EBT Excluding Unusual Items
1,1181,1611,2411,3251,2421,049
Gain (Loss) on Sale of Investments
0.25-3.53.610.58-0.03
Gain (Loss) on Sale of Assets
-4.32-4.33-12.2-2.78-1.72-1.17
Asset Writedown
13.28--52.75---
Other Unusual Items
69.2169.21109.0739.9553.0617.54
Pretax Income
1,1971,2231,2891,3631,2941,066
Income Tax Expense
131.66136.3889.82138.41105.0385.69
Earnings From Continuing Operations
1,0651,0861,1991,2241,189979.86
Minority Interest in Earnings
-9.61-18.37-4.78-6.69-21.25-6.19
Net Income
1,0561,0681,1941,2171,167973.66
Net Income to Common
1,0561,0681,1941,2171,167973.66
Net Income Growth
-3.84%-10.59%-1.89%4.28%19.90%30.20%
Shares Outstanding (Basic)
571571577580584587
Shares Outstanding (Diluted)
571571577580584587
Shares Change
-0.27%-1.02%-0.47%-0.68%-0.48%5.10%
EPS (Basic)
1.851.872.072.102.001.66
EPS (Diluted)
1.851.872.072.102.001.66
EPS Growth
-3.59%-9.66%-1.43%5.00%20.48%23.88%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
535.72737.38644.88569.44620.1395.39
Free Cash Flow Per Share
0.941.291.120.981.060.67
Dividend Per Share
1.3101.3101.2601.0520.8000.750
Dividend Growth
3.97%3.97%19.76%31.51%6.67%14.71%
Gross Margin
67.24%64.45%64.61%63.73%58.47%58.98%
Operating Margin
25.27%25.13%25.77%27.15%25.36%25.34%
Profit Margin
24.33%25.27%26.71%27.40%26.28%25.86%
Free Cash Flow Margin
12.35%17.45%14.42%12.81%13.96%10.50%
EBITDA
1,5411,5151,6161,6421,5441,340
EBITDA Margin
35.53%35.85%36.15%36.96%34.76%35.59%
D&A For EBITDA
445.08453.27464.2436.1417.56385.93
EBIT
1,0961,0621,1521,2061,126954.28
EBIT Margin
25.27%25.13%25.77%27.15%25.36%25.34%
Effective Tax Rate
11.00%11.15%6.97%10.16%8.12%8.04%
Revenue as Reported
4,3394,2264,4714,4444,4423,766
Advertising Expenses
-59.5954.3555.7941.445.1